Oncolytics Biotech Inc (ONCY)

Finanzdaten der Oncolytics Biotech Inc-Aktie (ONCY)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
	1.06%9.38	9.28
Research and Development	6.37%4.26	4.55
Operating Income/Loss	1.06%-9.38	-9.28
Income/Loss From Continuing Operations Before Tax	-9.34	-
Income Tax Expense/Benefit	0.10	-
	2.15%-9.44	-9.24
Attributable To Parent	2.15%-9.44	-9.24
Basic Average Shares	6.63%119.74	112.29
Diluted Average Shares	6.63%119.74	112.29
Basic Earnings Per Share	-0.08	-0.08
Diluted Earnings Per Share	-0.08	-0.08